Added to YB: 2022-02-22
Pitch date: 2022-02-22
PDSB [bullish]
PDS Biotechnology Corporation
-84.72%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies in the United States.
Market Cap
$43.1M
Pitch Price
$6.01
Price Target
N/A
Dividend
N/A
EV/EBITDA
-0.64
P/E
-0.92
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
PDS BIOTECHNOLOGY CORP PDSB
A summary for this pitch has not been created yet.
Read full article (0 min)